Griffonia simplicifolia

Griffonia simplicifolia is an African shrub containing 5-hydroxytryptophan (5-HTP), a direct precursor to serotonin that crosses the blood-brain barrier. The seeds provide standardized 5-HTP extract used primarily for mood support and sleep regulation.

Origin & History

Griffonia simplicifolia is a shrub native to West Africa, particularly Ghana, where its seeds serve as the primary source for supplements. The seeds are extracted using methods like 70% ethanol maceration or high-power ultrasonication (HPU), yielding extracts rich in 5-hydroxy-L-tryptophan (5-HTP), with HPU extracts achieving up to 82.8% w/w 5-HTP content.

Historical & Cultural Context

Griffonia simplicifolia seeds have been used in West African traditional medicine, particularly in Ghanaian healing systems, for mental well-being. Modern supplement use for serotonin promotion derives from this traditional context, though specific historical duration and detailed traditional protocols are not documented in available sources.

Health Benefits

• Mood support through serotonin pathway modulation - based on open-label depression trial (evidence: preliminary human data)
• Motion sickness reduction in pediatric patients - open-label trial (n=24) showed symptom improvement over 3 months (evidence: preliminary human data)
• Antifungal and anti-inflammatory effects - preclinical mouse model showed reduced vulvovaginal candidiasis infection (evidence: animal study only)
• Potential anti-cancer properties - in vitro studies showed antiproliferative activity against HeLa, HepG2, and MCF-7 cell lines (evidence: cell culture only)
• Antimicrobial activity against Staphylococcus aureus - demonstrated in laboratory testing (evidence: in vitro only)

How It Works

Griffonia simplicifolia seeds contain 5-hydroxytryptophan (5-HTP), which crosses the blood-brain barrier and converts directly to serotonin via aromatic L-amino acid decarboxylase. Increased serotonin levels enhance neurotransmission at 5-HT receptors, particularly affecting mood regulation, sleep cycles, and appetite control. Unlike dietary tryptophan, 5-HTP bypasses the rate-limiting tryptophan hydroxylase enzyme step.

Scientific Research

Human clinical evidence for Griffonia simplicifolia is limited to open-label trials without control groups, including a pediatric motion sickness study (n=24) and an unspecified depression trial using 12.8 mg 5-HTP doses. Preclinical research includes mouse models of vulvovaginal candidiasis (PMID: 40414710) and in vitro cancer cell line studies showing antiproliferative effects.

Clinical Summary

An open-label depression trial provided preliminary evidence for mood support through serotonin pathway modulation, though larger controlled studies are needed. A small open-label pediatric trial (n=24) showed motion sickness symptom improvement over 3 months of treatment. Most research focuses on isolated 5-HTP rather than whole Griffonia extract, with typical study dosages ranging from 50-300mg daily. The current evidence base consists primarily of preliminary human data and requires additional randomized controlled trials for definitive therapeutic claims.

Nutritional Profile

Griffonia simplicifolia is not consumed as a food ingredient for macronutrient or caloric value; its nutritional relevance is almost entirely defined by its seed bioactive alkaloid content. Primary bioactive compound: 5-hydroxytryptophan (5-HTP), present in seeds at approximately 6–14% of dry seed weight (some commercial extracts standardized to 98% 5-HTP). Secondary bioactive compounds include griffonilide (a furanone lactone), lectins (particularly Griffonia simplicifolia lectin I and II, GS-I and GS-II, which are N-acetylgalactosamine and galactose-binding), and trace amounts of related indole alkaloids. Protein content of whole seeds is estimated at 15–20% dry weight, though protein is not commercially exploited. Carbohydrate content includes complex polysaccharides and fiber components (~30–40% dry weight), with lectins being glycoprotein-bound. Fat content is low (<5% dry weight). Mineral content is not well characterized, but seeds contain modest levels of iron and magnesium typical of leguminous species. Bioavailability note: 5-HTP from Griffonia seed extract is well absorbed orally with ~70% bioavailability, readily crosses the blood-brain barrier without requiring a transport molecule (unlike L-tryptophan), and is rapidly converted to serotonin via aromatic L-amino acid decarboxylase. Lectins are largely denatured by heat processing and have limited systemic bioavailability when ingested.

Preparation & Dosage

Clinically studied dosages include 50 mg Griffonia simplicifolia extract (standardization unspecified) twice daily combined with 200 mg magnesium for pediatric motion sickness, and 60 mg extract standardized to 12.8 mg 5-HTP (~21%) twice daily for depression over 6 weeks. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Magnesium, Vitamin B6, L-theanine, Rhodiola rosea, Ashwagandha

Safety & Interactions

Common side effects include nausea, drowsiness, and gastrointestinal upset, particularly at higher doses above 300mg daily. Griffonia simplicifolia may interact with antidepressants (SSRIs, MAOIs) and serotonergic medications, potentially causing serotonin syndrome. Contraindicated during pregnancy and breastfeeding due to insufficient safety data. Individuals with scleroderma-like conditions should avoid use due to potential eosinophilia-myalgia syndrome risk associated with 5-HTP supplements.